Humana Inc.

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse Other stock markets 01:30:02 12/07/2025 am IST			5-day change	1st Jan Change
230.67 ^USD	-0.65%		-3.76%	-9.08%

11/07	Deutsche Bank Lowers Price Target on Humana to $224 From $262, Keeps Hold Rating	MT
10/07	Marsh Mclennan Appoints Bruce Broussard to Its Board of Directors, Effective July 9, 2025	CI

US Senate Republicans Consider Cutting Medicare Spending to Fund President's Tax Bill

Published on 06/06/2025 at 01:09

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Humana Inc.

Deutsche Bank Lowers Price Target on Humana to $224 From $262, Keeps Hold Rating	11/07	MT
Marsh Mclennan Appoints Bruce Broussard to Its Board of Directors, Effective July 9, 2025	10/07	CI
Centene shares plunge after health insurer withdraws forecast over Obamacare concerns	03/07	RE
Sector Update: Health Care Stocks Decline Wednesday Afternoon	02/07	MT
Humana Healthy Horizons Launches Medicaid Plan in Virginia	02/07	CI
Humana Launches Medicaid Plan in Virginia	02/07	MT
US Health Insurance Stocks Fall After Centene Withdraws 2025 EPS Guidance	02/07	MT
Raymond James Raises Price Target on Humana to $340 From $315, Maintains Outperform Rating	30/06	MT
Supreme Court Preserves 'Obamacare's Preventative Care Coverage Guarantee	27/06	MT
Humana Inc. Expands Science-Based Targets with New SBTi-Validated Target	24/06	CI
Humana Sets New Scope 3 Asset Class Level Target Aiming to Reduce Emissions From Lending Activities	24/06	MT
US health chief Kennedy gets pledge from insurers on prior authorization reform	24/06	RE
Health Insurers Pledge to Streamline Prior Authorization Process by 2027	23/06	MT
US Health Insurers Aim to Streamline Preapproval Process	20/06	MT
Humana Shows Multiple Levers to Drive EPS Growth, RBC Says	17/06	MT
Truist Cuts Price Target on Humana to $280 From $305, Keeps Hold Rating	17/06	MT
Truist Cuts Price Target on Humana to $280 From $305, Keeps Hold Rating	17/06	MT
Humana Inc. - Analyst/Investor Day	17/06
Mercy and Humana Team Up for the First Time to Open 65 Prime+ Clinics in Missouri	12/06	CI
Barclays Adjusts Price Target on Humana to $268 From $273	12/06	MT
Jefferies Adjusts Price Target on Humana to $244 From $287	11/06	MT
Wolfe Research Adjusts Price Target on Humana to $283 From $339, Maintains Outperform Rating	06/06	MT
PRESS DIGEST- Wall Street Journal - June 06	06/06	RE
Sector Update: Health Care Stocks Mixed Late Afternoon	06/06	MT
US Senate Republicans Consider Cutting Medicare Spending to Fund President's Tax Bill	06/06	MT

Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).

Employees

65,680

Sector

Managed Healthcare

Calendar

30/07 - Q2 2025 Earnings Release

More about the company